
|Podcasts|October 4, 2022
Transforming CMC Dossier Creation
Author(s)Dassault Systèmes BIOVIA
Through the adoption of a data driven and automated CMC Dossier generation process, pharmaceutical companies can reduce time-to-market while delivering significant cost savings to the organization. Eliminate errors, duplicate data entry and verification, create a digital chain of evidence and significantly reduce time spent on CMC authoring.
Trending on Pharmaceutical Technology
1
Why Big Pharma Is Betting Billions on Protein Degraders for Cancer
2
Enhancing Clinical Data Infrastructure for AI Research: A Strategic Guide for Pharma Professionals
3
CPHI Americas: The Business Case for Product Carbon Footprints in Pharma
4
Investigating Patient Complaints About Combination Products
5



